Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2026 Jan;17(1):122-124.
doi: 10.1177/21501351251360694. Epub 2025 Aug 12.

Contrasting the Performance of a Surgeon-Fashioned Extracellular Matrix Cylindrical Tricuspid Valve Versus a Mechanical Valve

Affiliations
Case Reports

Contrasting the Performance of a Surgeon-Fashioned Extracellular Matrix Cylindrical Tricuspid Valve Versus a Mechanical Valve

Darren Turner et al. World J Pediatr Congenit Heart Surg. 2026 Jan.

Abstract

We present a patient who as an infant required mitral and tricuspid valve replacement, with a mechanical valve used in the mitral position and a surgeon fashioned extracellular matrix of porcine small intestinal submucosa (SIS-ECM) (CorMatrix) valve in the tricuspid position. Five years later, the mechanical valve required replacement with a larger mechanical valve. Although the CorMatrix tricuspid valve did not show significant signs of thrombosis or calcification, it was also replaced with a mechanical valve. That mechanical valve thrombosed twice within one year and both times required surgery for replacement. After the second thrombotic event, however, a new hand sutured SIS-ECM valve was used in place of a mechanical valve. The new SIS-ECM tricuspid valve continues to function appropriately 17 months later, and the patient has remained asymptomatic.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: David L. S. Morales is a consultant for Abbott, Inc., Azyio, Inc., Berlin Heart, Inc., CorMatrix, Inc., Peca, Inc., Syncardia, Inc., and Xeltis, Inc., and a principal investigator for FDA trials sponsored by Peca, Inc. and Xeltis, Inc. Garick Hill is a consultant for Ultragenyx.

Publication types

LinkOut - more resources